Sterling Capital Management LLC Buys 4,223 Shares of Cigna Group $CI

Sterling Capital Management LLC increased its stake in Cigna Group (NYSE:CI) by 13.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,109 shares of the health services provider’s stock after purchasing an additional 4,223 shares during the quarter. Sterling Capital Management LLC’s holdings in Cigna Group were worth $9,816,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. James Investment Research Inc. lifted its holdings in shares of Cigna Group by 13.8% in the third quarter. James Investment Research Inc. now owns 4,668 shares of the health services provider’s stock valued at $1,269,000 after purchasing an additional 566 shares in the last quarter. Yousif Capital Management LLC grew its holdings in shares of Cigna Group by 3.8% during the third quarter. Yousif Capital Management LLC now owns 44,151 shares of the health services provider’s stock valued at $12,002,000 after buying an additional 1,610 shares in the last quarter. Compass Wealth Management LLC purchased a new position in shares of Cigna Group during the third quarter valued at $68,000. Brookstone Capital Management grew its holdings in shares of Cigna Group by 2.6% during the third quarter. Brookstone Capital Management now owns 1,636 shares of the health services provider’s stock valued at $445,000 after buying an additional 42 shares in the last quarter. Finally, Virtue Asset Management LLC raised its position in Cigna Group by 4.5% during the third quarter. Virtue Asset Management LLC now owns 4,154 shares of the health services provider’s stock valued at $1,129,000 after buying an additional 177 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the sale, the insider owned 27,256 shares in the company, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the transaction, the insider directly owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 22,730 shares of company stock worth $6,293,359 over the last three months. Company insiders own 0.60% of the company’s stock.

Cigna Group Stock Down 2.8%

NYSE:CI traded down $8.95 during mid-day trading on Friday, reaching $306.93. The stock had a trading volume of 1,780,316 shares, compared to its average volume of 1,614,929. The stock has a market cap of $81.10 billion, a P/E ratio of 12.70, a PEG ratio of 1.07 and a beta of 0.29. The business’s 50 day moving average is $281.72 and its 200 day moving average is $283.21. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $316.27.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The firm had revenue of $71.56 billion during the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company’s revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the company earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts predict that Cigna Group will post 30.50 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Guggenheim lifted their target price on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Royal Bank Of Canada reiterated an “outperform” rating and issued a $337.00 target price on shares of Cigna Group in a report on Thursday, October 1st. Piper Sandler reissued an “overweight” rating on shares of Cigna Group in a research report on Friday. Barclays raised their price target on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Finally, Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a research report on Friday, July 31st. Fifteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, Cigna Group presently has an average rating of “Moderate Buy” and an average target price of $338.24.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.